CASI Pharmaceuticals (CASI) Free Cash Flow (2020 - 2025)
CASI Pharmaceuticals (CASI) free cash flow from Dec 31, 2020 to Dec 31, 2025. The TTM CASI Pharmaceuticals (CASI) free cash flow is -$21M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
CASI Pharmaceuticals (CASI) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year | -29.45% |
| 3 Years | -8.03% |
| 5 Years | -5.38% |
| All Time | -5.38% |
Annual Free Cash Flow change of CASI Pharmaceuticals (CASI)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2025 | -$21M | -29.45% |
| 2024 | -$29M | +45.96% |
| 2023 | -$20M | -24.46% |
| 2022 | -$27M | -25.40% |
| 2021 | -$36M | +30.67% |
| 2020 | -$27M | N/A |
Comparison CASI Pharmaceuticals (CASI) five years free cash flow CAGR with competitors
CASI Pharmaceuticals (CASI) five years free cash flow CAGR is -5.38%.